A Washington Post report on March 28 that the US Department of Health and Human Services (HHS) forced the Food and Drug ...

Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his ...

By Manas Mishra (Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Ousting of Oklahoma Forestry Services Director Goeller draws criticism from AG Drummond, acknowledging the heroism of ...

Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...

Yes, there were some big hits like 'Reacher.' But pricey underperformers like 'Lord of the Rings' and 'Citadel' along with ...

Oppenheimer initiated coverage on shares of Ouster (NYSE:OUST – Free Report) in a research note released on Thursday, MarketBeat reports. The brokerage issued an outperform rating and a $16.00 price ...

The ice cream giant accused its parent company of removing its CEO because of his support for the brand’s activism.

On Monday, Ouster stock earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 95. IBD's proprietary RS Rating identifies technical performance by using a 1 (worst) to 99 ...

Hailed for his offensive talents, he quickly became the Rangers’ top prospect after the organization drafted him No. 23 ...

Ouster is a high-growth LiDAR technology company with a strong balance sheet, but breakeven is still several years away. The merger with Velodyne has expanded Ouster's customer base, improved ...